Perrigo Company PLC (PRGO)
Healthcare
Drug Manufacturers - Specialty & Generic
10.70 $
+5.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Perrigo Company PLC (PRGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -114 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 53 | 125 | 209 | -1.4 | 9.5 | 42 | 313 | -65 | 76 | 52 | 175 | -114 | 189 | |
| 94 | 91 | 86 | 81 | 82 | 82 | 80 | 80 | 86 | 85 | 56 | 83 | 311 | |
| 19 | 15 | 11 | 16 | 23 | 5.9 | 20 | 12 | 17 | 13 | 13 | 14 | 57 | |
| 22 | 40 | – | – | – | – | – | – | – | – | – | – | – | |
| -79 | -21 | 129 | -127 | -92 | -18 | 162 | -176 | -38 | -45 | 159 | -196 | -121 | |
| 20 | 32 | 27 | 25 | 28 | 27 | 38 | 26 | 19 | 22 | 27 | 14 | 82 | |
| -4.4 | -31 | -23 | -24 | -73 | 213 | -37 | -26 | -3.8 | -21 | -25 | -12 | -62 | |
| 37 | 39 | 38 | 38 | 38 | 38 | 40 | 41 | -39 | -40 | -40 | -40 | -159 | |
| -9.0 | -9.1 | – | – | – | 692 | -1,110 | -8.8 | -8.8 | -8.5 | -8.7 | -424 | -450 | |
| -49 | -43 | -45 | -60 | -50 | 653 | -1,154 | -62 | -54 | -50 | -54 | -45 | -204 | |
| 2.2 | 43 | 153 | -93 | -116 | 921 | -905 | -149 | 44 | -22 | 100 | -174 | -53 | |
| 33 | 93 | 182 | -27 | -19 | 15 | 275 | -90 | 57 | 30 | 149 | -127 | 108 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.